Chagas Disease (CD) is an anthropozoonosis caused by
Trypanosoma cruzi
. With complex pathophysiology and variable clinical presentation, CD outcome can be influenced by parasite persistence and the host immune response. Complement activation is one of the primary defense mechanisms against pathogens, which can be initiated via pathogen recognition by pattern recognition molecules (PRMs). Collectin-11 is a multifunctional soluble PRM lectin, widely distributed throughout the body, with important participation in host defense, homeostasis, and embryogenesis. In complex with mannose-binding lectin-associated serine proteases (MASPs), collectin-11 may initiate the activation of complement, playing a role against pathogens, including
T
.
cruz
i. In this study, collectin-11 plasma levels and
COLEC11
variants in exon 7 were assessed in a Brazilian cohort of 251 patients with chronic CD and 108 healthy controls. Gene-gene interactions between
COLEC11
and
MASP2
variants were analyzed. Collectin-11 levels were significantly decreased in CD patients compared to controls (p<0.0001). The allele rs7567833
G
, the genotypes rs7567833
AG
and rs7567833
GG
, and the
COLEC11
*
GGC
haplotype were related to
T
.
cruzi
infection and clinical progression towards symptomatic CD.
COLEC11
and
MASP2*CD
risk genotypes were associated with cardiomyopathy (p = 0.014; OR 9.3, 95% CI 1.2–74) and with the cardiodigestive form of CD (p = 0.005; OR 15.2, 95% CI 1.7–137), suggesting that both loci act synergistically in immune modulation of the disease. The decreased levels of collectin-11 in CD patients may be associated with the disease process. The
COLEC11
variant rs7567833
G
and also the
COLEC11
and
MASP2
*
CD
risk genotype interaction were associated with the pathophysiology of CD.